CNJ-016 Injection and Insulin degludec Subcutaneous
Determining the interaction of CNJ-016 Injection and Insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: vaccinia immune globulin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: n.a.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- CNJ-016 Injection-Insulin detemir
- CNJ-016 Injection-Insulin Detemir (Cartridges and Prefilled Syringes)
- CNJ-016 Injection-Insulin Detemir (Vials)
- CNJ-016 Injection-Insulin detemir Subcutaneous
- CNJ-016 Injection-Insulin glargine
- CNJ-016 Injection-Insulin Glargine (U-100) Cartridge Systems and Pens
- Insulin degludec Subcutaneous-Co-Gesic
- Insulin degludec Subcutaneous-Co-trimoxazole
- Insulin degludec Subcutaneous-Co-Veratrol
- Insulin degludec Subcutaneous-Coagadex
- Insulin degludec Subcutaneous-Coagulation factor IX
- Insulin degludec Subcutaneous-Coagulation factor ix recombinant Intravenous